Literature DB >> 12471222

Comparison of genetic services with and without genetic registers: knowledge, adjustment, and attitudes about genetic counselling among probands referred to three genetic clinics.

C Wright1, L Kerzin-Storrar, P R Williamson, A Fryer, A Njindou, O Quarrell, D Donnai, D Craufurd.   

Abstract

Genetic register services incorporating long term follow up and a proactive approach to at risk subjects have been recommended as a way of improving access to genetic counselling for families with dominant or X linked genetic disorders and chromosome translocations. The aims of the present study were to evaluate the psychosocial benefits and drawbacks of long term family contact, and to evaluate the attitudes of probands and their general practitioners towards proactive genetic counselling. We interviewed 192 people referred to three regional genetic clinics because of a family history of Duchenne or Becker muscular dystrophy, myotonic dystrophy, or chromosome translocations, and 43 of the referring GPs. Probands attending the centre using a genetic register approach were compared with those from the two centres offering the standard clinical genetic service. A very high proportion of probands in both groups were well informed about the genetic risks to themselves and their children, were satisfied with the service they had received from their local genetic clinic, and felt adequately prepared to discuss the family illness with their children. The register probands expressed approval of the ongoing contact and open access provided by the register service. Asked whether previously unaware relatives should be informed of their at risk status, 98% (188/192) said it was acceptable for this information to be disclosed by a family member, while three quarters of the probands (149/192) and just over half the GPs (27/43) thought it acceptable for the genetic service to approach them; a similar proportion of both GPs and probands also found it acceptable for GPs to do so. More than half the probands (107/190) thought it was the family's responsibility to pass on genetic risk information, but 43% said that either the genetic service or the GP should be responsible for this. The findings show that the genetic register approach incorporating long term follow up and a proactive approach to genetic counselling is highly acceptable to the families concerned, and although the register and non-register probands did not differ significantly on any of the main outcome measures used in this relatively short term study, it may be that the continuing contact associated with the register approach offers long term benefits, especially for those genetic conditions where medical surveillance may have an impact on the prognosis.

Entities:  

Mesh:

Year:  2002        PMID: 12471222      PMCID: PMC1757214          DOI: 10.1136/jmg.39.12.e84

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  16 in total

1.  Genetic registers in clinical practice: a survey of UK clinical genetics.

Authors:  J C Dean; D R Fitzpatrick; P A Farndon; H Kingstn; D Cusine
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

2.  A report on genetic registers. Based on the report of the Clinical Genetics Society Working Party.

Authors:  A E Emery; C Brough; M Crawfurd; P Harper; R Harris; G Oakshott
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

3.  Adult polycystic kidney disease: knowledge, experience, and attitudes to prenatal diagnosis.

Authors:  K A Hodgkinson; L Kerzin-Storrar; E A Watters; R Harris
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

4.  Satisfaction with genetic counseling: dimensions and measurement.

Authors:  S Shiloh; O Avdor; R M Goodman
Journal:  Am J Med Genet       Date:  1990-12

5.  Evaluation of genetic counselling: recall of information, post-counselling reproduction, and attitude of the counsellees.

Authors:  M Somer; H Mustonen; R Norio
Journal:  Clin Genet       Date:  1988-12       Impact factor: 4.438

6.  A register based system for gene tracking in Duchenne muscular dystrophy.

Authors:  A P Read; L Kerzin-Storrar; R C Mountford; R G Elles; R Harris
Journal:  J Med Genet       Date:  1986-12       Impact factor: 6.318

7.  Proposed: an international code of ethics for medical genetics.

Authors:  D C Wertz; J C Fletcher
Journal:  Clin Genet       Date:  1993-07       Impact factor: 4.438

8.  Transmitting genetic risk information in families: attitudes about disclosing the identity of relatives.

Authors:  J T Wilcke; N Seersholm; A Kok-Jensen; A Dirksen
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

9.  The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.

Authors:  J Burn; P Chapman; J Delhanty; C Wood; F Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

10.  Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families.

Authors:  C M Benjamin; A Colley; D Donnai; H Kingston; R Harris; L Kerzin-Storrar
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

View more
  6 in total

1.  Stakeholder Perspectives on Overcoming Barriers to Cascade Testing in Lynch Syndrome: A Qualitative Study.

Authors:  Swetha Srinivasan; Heather Hampel; Jennifer Leeman; Amit Patel; Alanna Kulchak Rahm; Daniel S Reuland; Megan C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

2.  Quality in genetic counselling for presymptomatic testing--clinical guidelines for practice across the range of genetic conditions.

Authors:  Heather Skirton; Lesley Goldsmith; Leigh Jackson; Aad Tibben
Journal:  Eur J Hum Genet       Date:  2012-08-15       Impact factor: 4.246

3.  Evaluation of the template letter regarding the disclosure of genetic information within the family in France.

Authors:  Cécile Zordan; Laetitia Monteil; Emmanuelle Haquet; Christophe Cordier; Eva Toussaint; Pauline Roche; Virginie Dorian; Aline Maillard; Edouard Lhomme; Laura Richert; Laurent Pasquier; Linda Akloul; Nicolas Taris; Didier Lacombe
Journal:  J Community Genet       Date:  2019-03-27

4.  Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.

Authors:  Rhona MacLeod; Anna Beach; Sasha Henriques; Jasmin Knopp; Katie Nelson; Lauren Kerzin-Storrar
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

Review 5.  Perspectives on neurological patient registries: a literature review and focus group study.

Authors:  Lawrence Korngut; Gail MacKean; Lisa Casselman; Megan Johnston; Lundy Day; Darren Lam; Diane Lorenzetti; Janet Warner; Nathalie Jetté; Tamara Pringsheim
Journal:  BMC Med Res Methodol       Date:  2013-11-09       Impact factor: 4.615

Review 6.  Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.

Authors:  Lauren C Tindale; Almira Zhantuyakova; Stephanie Lam; Michelle Woo; Janice S Kwon; Gillian E Hanley; Bartha Knoppers; Kasmintan A Schrader; Stuart J Peacock; Aline Talhouk; Trevor Dummer; Kelly Metcalfe; Nora Pashayan; William D Foulkes; Ranjit Manchanda; David Huntsman; Gavin Stuart; Jacques Simard; Lesa Dawson
Journal:  Curr Oncol       Date:  2022-06-30       Impact factor: 3.109

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.